Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Net Change in Cash : ¥6,803 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Jiangsu Hengrui Pharmaceuticals Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥468 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥6,803 Mil.

Jiangsu Hengrui Pharmaceuticals Co Net Change in Cash Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Net Change in Cash Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

1,165.19

5,431.87

2,657.37

1,417.28

5,734.09

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-600.95	1,880.39	1,196.77	3,257.88	467.87

Jiangsu Hengrui Pharmaceuticals Co Net Change in Cash Calculation

Jiangsu Hengrui Pharmaceuticals Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	7643.665	+	1222.315	+	-3144.426	+	12.533
	=	5,734

Jiangsu Hengrui Pharmaceuticals Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 1254.599 + -750.39 + -18.135 + -18.208

= 468

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6,803 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Hengrui Pharmaceuticals Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Net Change in Cash

Comparable Companies

SHSE:600436 SZSE:002422 SZSE:002019 SZSE:300357 SHSE:600771 SZSE:301096 SZSE:300109 SHSE:600713 SZSE:000411 SZSE:301507 LLY JNJ MRK ABBV LSE:AZN XSWX:ROG XSWX:NOVN PFE AMGN XPAR:SAN

Traded in Other Exchanges

N/A

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines